Twenty-Year History of the Evolution of Stroke Thrombolysis With Intravenous Alteplase to Reduce Long-Term Disability
- 1 August 2015
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Stroke
- Vol. 46 (8), 2341-2346
- https://doi.org/10.1161/strokeaha.114.007564
Abstract
No abstract availableThis publication has 44 references indexed in Scilit:
- World Stroke Organization Global Stroke Services Guidelines and Action PlanInternational Journal of Stroke, 2014
- Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trialsThe Lancet, 2014
- Guidelines for the Early Management of Patients With Acute Ischemic StrokeStroke, 2013
- Patient outcomes from symptomatic intracerebral hemorrhage after stroke thrombolysisNeurology, 2011
- Thrombolysis with Alteplase 3 to 4.5 Hours after Acute Ischemic StrokeThe New England Journal of Medicine, 2008
- Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational studyThe Lancet, 2007
- Findings From the Reanalysis of the NINDS Tissue Plasminogen Activator for Acute Ischemic Stroke Treatment TrialStroke, 2004
- Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II)The Lancet, 1998
- Intracerebral Hemorrhage After Intravenous t-PA Therapy for Ischemic StrokeStroke, 1997
- Tissue Plasminogen Activator for Acute Ischemic StrokeThe New England Journal of Medicine, 1995